Richard I Steinhart Bio Xcel Therapeutics, Inc. (BTAI) insider trading activity

Richard I Steinhart is Chief Financial Officer of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 1,441 shares of BTAI, which is worth approximately $2,521. The most recent transaction as insider was on Feb 01, 2021, when has been sold 3,750 shares (Common Stock) at a price of $48.15 per share, resulting in proceeds of $180,563. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.44K

4.95% 3M change

73.69% 12M change

Total Value Held $2,521

Richard I Steinhart Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 01 2021	SELL Open market or private sale	$180,563 $48.15 p/Share	3,750 Reduced 71.43%	1,500 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$20,813 $5.55 p/Share	3,750 Added 41.67%	5,250 Common Stock

Also insider at

ATOS

ATOSSA THERAPEUTICS, INC. Healthcare

ATNM

Actinium Pharmaceuticals, Inc. Healthcare

Director

RIS